Bio Impact Capital LLC Compass Therapeutics, Inc. Transaction History
Bio Impact Capital LLC
- $511 Million
- Q2 2025
A detailed history of Bio Impact Capital LLC transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Bio Impact Capital LLC holds 5,622,505 shares of CMPX stock, worth $17.8 Million. This represents 2.86% of its overall portfolio holdings.
Number of Shares
5,622,505
Previous 8,442,783
33.4%
Holding current value
$17.8 Million
Previous $16 Million
8.87%
% of portfolio
2.86%
Previous 2.97%
Shares
6 transactions
Others Institutions Holding CMPX
# of Institutions
102Shares Held
101MCall Options Held
18.2KPut Options Held
2.51M-
Orbimed Advisors LLC San Diego, CA15.2MShares$48.2 Million1.41% of portfolio
-
Tang Capital Management LLC San Diego, CA13.5MShares$42.8 Million2.1% of portfolio
-
Blackstone Inc New York, NY10MShares$31.8 Million0.12% of portfolio
-
Suvretta Capital Management, LLC New York, NY7.15MShares$22.7 Million0.64% of portfolio
-
Black Rock Inc. New York, NY6.61MShares$21 Million0.0% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $321M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...